U.S. Professional Services Stock News

NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Monster Beverage’s Record Quarter Highlights Growing Reliance On International Demand

Monster Beverage (NasdaqGS:MNST) reported record quarterly revenue in its latest results. Fourth quarter net sales crossed US$2b for the first time in the company’s history. International operations, particularly in the EMEA region, were a key driver of the performance. Monster Beverage is a major player in the global energy drink market, with a portfolio that targets on the go consumers looking for functional beverages. The latest quarter puts the focus back on the underlying business...
NYSE:ATO
NYSE:ATOGas Utilities

Atmos Energy Lawsuit Puts Pipeline Safety And Earnings Outlook Under Scrutiny

Atmos Energy (NYSE:ATO) is facing a lawsuit after a gas main leak led to a catastrophic house explosion in a Lake Dallas neighborhood. The incident caused severe injuries and triggered an extended neighborhood evacuation while crews addressed the gas infrastructure issue. Plaintiffs allege Atmos Energy failed to properly maintain and monitor its gas system, raising questions about safety practices and risk controls. Atmos Energy, a regulated natural gas utility, sits at the center of...
NasdaqGS:MCRI
NasdaqGS:MCRIHospitality

Is Monarch Casino & Resort (MCRI) Offering Good Value After Recent Share Price Pullback

Wondering if Monarch Casino & Resort at around US$93.98 is offering a fair price or asking too much for its chips on the table. The stock has seen a 2.6% decline over the last 7 days and is down 2.0% over the past month, yet it shows a 21.4% return over 1 year and 68.0% over 5 years, which can influence how investors think about both risk and opportunity. Recent attention on Monarch Casino & Resort has focused on its role within the broader hospitality and gaming space, with investors...
NYSE:AXS
NYSE:AXSInsurance

Is It Time To Reassess AXIS Capital (AXS) After Its Strong Multi Year Share Price Run?

Setting Up The Valuation Picture For AXIS Capital Holdings AXIS Capital Holdings might be on your radar if you are asking whether the current share price lines up with the underlying value of the business, and this article is built to help you answer exactly that question. At a last close of US$98.91, the stock has seen a 0.7% return over the last 7 days, a 3.6% decline over 30 days, a 5.1% decline year to date, a 1.1% return over 1 year, and very large gains of 93.7% over 3 years and 122.0%...
NasdaqGM:VERI
NasdaqGM:VERISoftware

A Look At Veritone (VERI) Valuation After New Oracle Cloud Infrastructure Agreement

Veritone (VERI) has drawn fresh attention after announcing a multi-year agreement with Oracle to move its AI solutions, including aiWARE, Veritone Data Refinery, and Veritone Data Marketplace, onto Oracle Cloud Infrastructure. See our latest analysis for Veritone. The Oracle agreement and recent product updates arrive after a steep reset in expectations, with the share price down 61.6% year to date and a 5 year total shareholder return decline of 92.5%, pointing to fading momentum as...
NasdaqCM:SLS
NasdaqCM:SLSBiotechs

A Look At SELLAS Life Sciences Group (SLS) Valuation After SLS009 Data And New Equity Offering Plans

SELLAS Life Sciences Group (SLS) is drawing attention after releasing preclinical data on its CDK9 inhibitor SLS009 in acute myeloid leukemia and filing both a universal shelf registration and a US$150 million at-the-market equity offering. See our latest analysis for SELLAS Life Sciences Group. Those preclinical SLS009 data and the fresh shelf and at the market filing are landing after a sharp run, with the 1 year total shareholder return near 3x and a 52.09% 90 day share price return, even...
NYSE:KRMN
NYSE:KRMNAerospace & Defense

Karman Holdings (KRMN) Is Down 15.4% After Raising 2026 Revenue Guidance And Backlog Tops US$1 Billion - Has The Bull Case Changed?

Karman Holdings Inc. recently reported past fourth-quarter 2025 results showing sales of US$134.49 million and net income of US$7.71 million, with full-year 2025 sales reaching US$471.50 million and net income of US$17.37 million. The company also raised its 2026 revenue outlook to US$715 million–US$730 million as its funded backlog moved beyond US$1 billion and recent acquisitions broadened its space and defense capabilities. Now, we’ll examine how the raised 2026 revenue guidance and...
NYSE:DOC
NYSE:DOCHealth Care REITs

What Healthpeak Properties (DOC)'s New US$400 Million Undrawn Term Loan Means For Shareholders

On March 23, 2026, Healthpeak Properties, Inc. closed a new US$400,000,000 unsecured delayed-draw term loan facility maturing in March 2031, with interest set at SOFR plus 80 basis points and the facility undrawn at closing. The participation of major lenders such as BofA Securities, JPMorgan, and Wells Fargo Securities underscores lender confidence in Healthpeak’s balance sheet strength and financing flexibility. Next, we’ll examine how this new undrawn US$400,000,000 term loan facility...
NasdaqGS:REG
NasdaqGS:REGRetail REITs

Regency Centers Index Exit Puts Focus On Valuation And Buyback Capacity

Regency Centers (NasdaqGS:REG) has been removed from the FTSE All-World Index. The change affects the company’s presence in a widely followed global equity benchmark used by many index funds. For investors tracking NasdaqGS:REG, the index removal comes with the stock around $74.3 and a value score of 5. The shares show a 9.3% return year to date and 6.2% over the past year, with longer term returns of 37.2% over three years and 57.5% over five years. This type of index change can influence...
NasdaqGS:BGC
NasdaqGS:BGCCapital Markets

Is It Too Late To Consider BGC Group (BGC) At Around US$9.40 Today?

Wondering if BGC Group at US$9.40 is pricing in its true potential, or if the market is asking you to pay too much for the growth on offer? The stock has returned 0.1% over the last week and 5.1% year to date, with a 3.3% return over the past year and very large gains over the last 3 and 5 years that set the backdrop for any valuation check today. Recent coverage around BGC Group has kept attention on how the business is positioned within capital markets and how it responds to changing...
NYSE:AAP
NYSE:AAPSpecialty Retail

Advance Auto Parts Extends NASCAR Deal As Investors Weigh Turnaround Story

Advance Auto Parts renewed its partnership with Team Penske and NASCAR Cup Series champion Ryan Blaney for upcoming NASCAR seasons. The agreement keeps Advance Auto Parts branding on the No. 12 Ford Mustang and at key NASCAR events. The deal includes planned in store appearances and fan engagement events featuring Ryan Blaney. For investors watching NYSE:AAP, this renewed motorsports partnership comes with the stock trading at $51.57. Shares are up 9.6% over the past week, 32.6% year to...
NYSE:IEX
NYSE:IEXMachinery

Has The Recent Pullback In IDEX (IEX) Opened A Valuation Opportunity For Investors

If you are wondering whether IDEX at around US$186.55 is offering fair value or a potential mispricing, you are not alone. The stock has returned 1.3% over the last 7 days, 4.2% year to date and 4.7% over the past year, but this sits alongside a 9.5% decline over the last 30 days and negative 3 and 5 year returns. These mixed returns have kept attention on IDEX, with investors weighing up how its business profile and industry position compare with current expectations. Recent coverage has...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

The Bull Case For Capital Clean Energy Carriers (CCEC) Could Change Following Earnings Jump And Deleveraging Pivot

In early March 2026, Capital Clean Energy Carriers Corp. reported a 36.5% year-on-year rise in Q4 2025 net income, took delivery of its first LCO2/multi-gas carrier Active funded partly by a 12-year ECA-backed loan, and completed the profitable sale of the M/V Buenaventura Express to lower debt. Together, the earnings jump, fleet upgrade into specialized multi-gas capacity, and balance sheet improvement offer a clearer view of how the company is aligning growth with capital discipline. We...
NasdaqGS:DSGR
NasdaqGS:DSGRTrade Distributors

Is It Time To Reassess Distribution Solutions Group (DSGR) After The US$29.50 Go Private Proposal

How Distribution Solutions Group's recent share price sets up a valuation check Before getting into detailed valuation work, it helps to understand how Distribution Solutions Group's share price has been behaving and what recent information is shaping expectations. Over the last week, the stock has been relatively steady with a 0.2% decline, but the past month has seen a sharper 12.6% pullback and the year to date return sits at a 7.2% loss, with the last 12 months at a 6.8% loss, even though...
NasdaqGS:LGN
NasdaqGS:LGNConstruction

Legence (LGN) Q3 Revenue Strength Tests Bullish Narratives On Path To Profitability

Legence (LGN) has just posted another busy quarter, with Q3 FY 2025 revenue of US$708.0 million and a small loss, as Basic EPS landed at a US$0.02 loss and net income excluding extra items was a US$1.1 million loss. The company has seen revenue move from US$560.8 million in Q3 FY 2024 to US$708.0 million in Q3 FY 2025. Over the trailing 12 months, revenue reached about US$2.4 billion against a trailing 12 month net loss of US$19.8 million, putting the spotlight squarely on scaling margins...
NYSE:DLB
NYSE:DLBSoftware

Is Dolby Laboratories (DLB) Offering Value After Recent Share Price Pullback

If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in. The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years. Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader...
NasdaqGM:ZNTL
NasdaqGM:ZNTLBiotechs

Zentalis Pharmaceuticals (ZNTL) Posts Zero Revenue Challenging Bullish Revenue Recovery Narratives

Zentalis Pharmaceuticals (ZNTL) has just posted its FY 2025 first half results with total revenue at US$0 million, basic EPS at a loss of US$1.05, and net income excluding extraordinary items at a loss of US$75.2 million. This puts the focus firmly on expense control and cash burn. Over the recent periods, the company has seen revenue move from US$40.6 million in the first half of 2024 to US$26.9 million in the second half of 2024, before dropping to zero in the latest half. Half year basic...
NYSE:JBS
NYSE:JBSFood

JBS Index Removal Puts Focus On Valuation Momentum And Dividend Risks

JBS (NYSE:JBS) has been removed from the FTSE All-World Index. The change affects the company’s presence in a major global equity benchmark tracked by many passive funds. The decision may influence how both current and prospective shareholders assess JBS within global portfolios. JBS, trading at $17.03, has seen a return of 19.5% over the past week and 20.1% year to date, with a 3.8% return over the past 30 days. With a value score of 6, the stock sits in a segment of the market that some...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Is Arch Capital Group (ACGL) Still Attractive After Recent Share Price Softness?

Wondering whether Arch Capital Group at around US$93 per share still offers value, or if most of the opportunity is already reflected in the price? This article focuses squarely on what the current valuation signals might be telling you. The stock has gained 1.2% over the last 7 days, while showing a 6.0% decline over 30 days and a slight 0.5% decline year to date, alongside a 1.7% decline over the last year and longer term returns of 44.8% over 3 years and 149.3% over 5 years. Recent...
NasdaqGS:BHF
NasdaqGS:BHFInsurance

A Look At Brighthouse Financial (BHF) Valuation After Recent Share Price Weakness

Brighthouse Financial (BHF) is back on investors’ radar after a recent share move. The stock is trading around $59.98, with performance over the past month and past 3 months in focus. See our latest analysis for Brighthouse Financial. Recent price action has softened, with a 90 day share price return of a 7.51% decline and a year to date share price return of a 7.11% decline. However, the 1 year total shareholder return of 4.22% and 3 year total shareholder return of 35.98% indicate that...
NYSE:EG
NYSE:EGInsurance

Everest Group Canada Sale And Rating Review Create Valuation Questions

Everest Group (NYSE:EG) has agreed to sell 100% of Everest Insurance Company of Canada to The Wawanesa Mutual Insurance Company. Following the announcement, AM Best placed Everest Canada’s financial strength and credit ratings under review with negative implications. The proposed transaction is subject to regulatory approvals and closing conditions, adding timing and execution uncertainty for investors and policyholders. Everest Group is a global reinsurance and insurance provider, and its...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Verra Mobility’s Sales Growth Meets Profitability Strains And Cooling Sentiment

Verra Mobility, NasdaqCM:VRRM, is reporting long term sales growth alongside pressure on free cash flow margins. Recent quarterly results show weaker profitability, prompting questions about investment needs and cost control. Investor sentiment has cooled, with the share price at $13.88 and a 37.8% decline year to date. For shareholders, the story around Verra Mobility is no longer just about sales momentum. The stock is down 37.8% year to date and 31.3% over the past year, with the current...
NasdaqGS:SFD
NasdaqGS:SFDFood

Smithfield Foods (SFD) Is Up 15.4% After Record Profit And Nathan’s Famous Deal - What's Changed

In March 2026, Smithfield Foods reported higher fourth-quarter and full-year 2025 results, issued 2026 guidance for low-single-digit sales growth, announced a quarterly dividend of US$0.3125 per share, and outlined an agreement to acquire the Nathan's Famous packaged meats brand while continuing to evaluate additional M&A opportunities. A key takeaway for investors is Smithfield Foods’ record 2025 operating profit of US$1.30 billion and margin expansion to 8.6%, highlighting improved...
NasdaqGS:SPRO
NasdaqGS:SPROBiotechs

Spero Therapeutics (SPRO) Earnings Turn Positive Challenging Bearish Profitability Narratives

Spero Therapeutics (SPRO) closed FY 2025 with fourth quarter revenue of US$41.3 million and basic EPS of US$0.56, alongside trailing twelve month revenue of US$66.8 million and EPS of roughly US$0.15 that mark a shift into profitability over the period. Over recent quarters, the company has seen revenue range from US$5.4 million to US$41.3 million with quarterly EPS moving from a loss of about US$0.25 per share at the start of FY 2025 to a profit in the latest quarter, providing a clearer...